Econazole

• Description:

  Econazole ((±) -Econazol) is an orally active imidazole antifungal agent, as well as a cytochrome P-450 inhibitor and a blocker of calcium and manganese ion uptake. Econazole is active against a variety of fungi and some Gram-positive bacteria, but has no significant activity against Gram-negative bacteria. Econazole can inhibit the synthesis of prostaglandins and can also induce liver damage[1][2][3][4][5].

• Product Name Alternative:

  (±) -Econazol

• UNSPSC:

  12352005

• Hazard Statement:

  H302

• Target:

  Bacterial; Calcium Channel; Cytochrome P450; Fungal

• Type:

  Reference compound

• Related Pathways:

  Anti-infection; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection; Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/Econazole.html

• Concentration:

  10mM

• Purity:

  99.93

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  ClC1=CC=C(C(OCC2=CC=C(Cl)C=C2)CN3C=CN=C3)C(Cl)=C1

• Molecular Formula:

  C18H15Cl3N2O

• Molecular Weight:

  381.68

• Precautions:

  H302

• References & Citations:

  [1]Mason MJ, et al. Inhibition of Ca2+ transport pathways in thymic lymphocytes by econazole, miconazole, and SKF 96365. Am J Physiol. 1993 Mar;264 (3 Pt 1) :C654-62.|[2]Heel RC, et al. Econazole: a review of its antifungal activity and therapeutic efficacy. Drugs. 1978 Sep;16 (3) :177-201.|[3]Hill K, et al. Inhibition of TRPM2 channels by the antifungal agents clotrimazole and econazole. Naunyn Schmiedebergs Arch Pharmacol. 2004 Oct;370 (4) :227-37.|[4]Köfeler HC, et al. Effect of cytochrome P-450 inhibitors econazole, bifonazole and clotrimazole on prostanoid formation. Br J Pharmacol. 2000 Jul;130 (6) :1241-6.|[5]Liu CF, et al. Antioxidative natural product protect against econazole-induced liver injuries. Toxicology. 2004 Mar 1;196 (1-2) :87-93.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  Launched

• Citation 01:

  Adv Sci (Weinh) . 2024 Jul 23:e2310126.|Anal Chem. 2025 Jun 3;97 (21) :11099-11109.|BMC Cancer. 2025 May 28;25 (1) :956.|Oxid Med Cell Longev. 2019 Aug 5:2019:8265958.|Anal Biochem. 2019 Dec 15;587:113463.

• CAS Number:

  [27220-47-9]